To the Editor.—I read with some concern the article by Nancy Roach1 with accompanying forward to the CAP Strategic Science Symposium by Davey and Zarbo2 in the August 2003 issue of the Archives. In particular, her admonition that the sexually transmitted nature of human papillomavirus infection should be de-emphasized may be politically correct, but is scientifically, epidemiologically, and therapeutically irresponsible. Only by emphasizing the sexually transmitted nature of this virus and its potentially lethal progeny (invasive carcinoma of the cervix) can the medical profession prevent infection and/or prevent transmission. This approach requires that physicians advocate abstinence, monogamy, or the use of a barrier protection. By de-emphasizing the sexual nature of this disease, we will never win the battle against this insidious carcinogenic agent. I know of no responsible medical professional who thinks we should de-emphasize the dangers of smoking (an extremely effective method of transmitting the carcinogenic agents in tobacco)!
Skip Nav Destination
Article navigation
LETTERS TO THE EDITOR|
January 01 2004
Delivering Human Papillomavirus Testing to the Public
Frederick E. Dennstedt, MD
Frederick E. Dennstedt, MD
Parrish Medical Center, Titusville, FL 32796
Search for other works by this author on:
Arch Pathol Lab Med (2004) 128 (1): 10.
Citation
Frederick E. Dennstedt; Delivering Human Papillomavirus Testing to the Public. Arch Pathol Lab Med 1 January 2004; 128 (1): 10. doi: https://doi.org/10.5858/2004-128-10a-DHPTTT
Download citation file:
Sponsored Video
93
Views
Citing articles via
Neural or Neural-Related Colorectal Lesion Incidence Varies by Site, and Multifocal Cases Are Often Syndromic: Insights From a Series of 593 Patients
Irene Y. Chen, MD, Raul S. Gonzalez, MD, Aaron R. Huber, DO
SARS-CoV-2 Placentitis: A Review of Pathologic Findings and Discussion of Differential Diagnosis
Sarah H. Farran, MD, Raja Rabah, MD, Caroline Simon, MD
Evaluation of Laboratory-Derived Immunohistochemical Assays for Folate Receptor α Expression in Epithelial Ovarian Cancer and Comparison With a Companion Diagnostic
Emily Deutschman, PhD, Regan Fulton, MD, PhD, Callum M. Sloss, PhD
Primary Angiitis of the Central Nervous System and Its Mimics: A Pattern-Based Approach to Biopsies for Central Nervous System Vasculitis
Ryan Cecchi, MD, Nicole Becker, MD, Kyle S. Conway, MD
Diagnosis and Prevention of Transition Zone Pull-through in Patients With Hirschsprung Disease
Raj P. Kapur, MD PhD, Vinay Prasad, MD, Shruthi Srinivas, MD, MPH, Elizabeth Thomas, MSn, Richard Wood, MD, Caitlin Smith, MD
Breast Cancer Biopsies With Group 2 and Group 4 Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization Results Should Have Repeated Testing on Excision
Kristina-Ana Klaric, BSc, MD, Denis Gravel, MD, Nina Chang, BSc, MD, Sarah Strickland, BSc, MD, Phillip Williams, BSc, MSc, MD
Clinical Evaluation of the Heparin Therapeutic Window Using Activated Clotting Time in Neurological Interventional Radiology at an Academic Medical Center
Melody B. Nelson, DCLS, Amitava Dasgupta, PhD, X. Long Zheng, MD, PhD
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms
Savanah D. Gisriel, MD, MPH, Fnu Aakash, MD, John M. Bennett, MD, Robert P. Hasserjian, MD, Sanam Loghavi, MD, Amy E. DeZern, MD, MHS, Valeria Santini, MD, Michael R. Savona, MD, Andrew M. Brunner, MD, Rena Buckstein, MD, FRCPC, Andrew H. Wei, MBBS, PhD, Matteo G. Della Porta, MD, Rami S. Komrokji, MD, Uma M. Borate, MD, MBBS, Mikkael A. Sekeres, MD, Uwe Platzbecker, MD, Pierre Fenaux, MD, PhD, Gail J. Roboz, MD, Arjan van de Loosdrecht, MD, PhD, Amer M. Zeidan, MBBS, MHS, Mina L. Xu, MD
The State of Pathology Student Interest Groups in Allopathic and Osteopathic Medical Schools in the United States: Current Practices and Opportunities for Improvement
Cullen M. Lilley, MD, MS, MA, Kamran M. Mirza, MD, PhD, Kalisha Hill, MD, MBA
Differentiation Versus Grade for Pancreatic Neuroendocrine Neoplasms
Guido Rindi, MD, PhD, Frediano Inzani, MD, PhD